Che-Haorz Wu

Title: Che-Haorz Wu: Innovator in Glycoprotein Production

Introduction

Che-Haorz Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant glycoproteins. With a total of 2 patents, his work has advanced the understanding and application of glycosylation in biopharmaceuticals.

Latest Patents

Wu's latest patents focus on methods for producing recombinant glycoproteins with modified glycosylation. These patents detail genetically engineered host animal cells capable of producing glycoproteins with altered glycosylation patterns, such as defucosylation and/or monoglycosylation. The engineered host animal cells can express fucosidase, endoglycosidase, or both, enhancing the efficiency and specificity of glycoprotein production.

Career Highlights

Throughout his career, Che-Haorz Wu has worked with notable companies in the biotechnology sector, including Oneness Biotech Co. and Fountain Biopharma Inc. His expertise in glycoprotein production has positioned him as a key figure in the development of innovative biopharmaceutical solutions.

Collaborations

Wu has collaborated with several professionals in his field, including Nien-Yi Chen and Hung-Chi Chen. These collaborations have further enriched his research and contributed to the advancement of glycoprotein technologies.

Conclusion

Che-Haorz Wu's contributions to the field of biotechnology, particularly in glycoprotein production, highlight his innovative spirit and dedication to advancing science. His patents and collaborations reflect a commitment to improving biopharmaceutical processes and outcomes.